Ring Therapeutics, Inc is a revolutionary biotechnology company based in Cambridge, MA that is pioneering the future of programmable genetic medicines. Their Anellogy platform harnesses the natural human commensal virome to develop anellovirus-based therapies capable of tissue and cellular tropism, payload versatility, potency, and redosability.
By expanding their knowledge of anelloviruses, Ring Therapeutics is transforming commensal viruses into life-saving therapies, exploiting their unique properties and tissue tropisms to deliver diverse therapeutic modalities to a wide array of tissues. With a team of leading experts and pioneers, they are pushing the boundaries of what's possible to bring the next generation of therapies to patients with significant need.
Generated from the website